Gene · 8739
Papers1,778
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,778
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Involvement of Bcl-2 Family Proteins in Tetraploidization-Related Senescence. | Int J Mol Sci | 2023 | 37047342 | PubTator, text mining | PubMed |
| The Role of Gasotransmitter-Dependent Signaling Mechanisms in Apoptotic Cell Death in Cardiovascular, Rheumatic, Kidney, and Neurodegenerative Diseases and Mental Disorders. | Int J Mol Sci | 2023 | 37046987 | PubTator, text mining | PubMed |
| Metabolic Interventions in Tumor Immunity: Focus on Dual Pathway Inhibitors. | Cancers (Basel) | 2023 | 37046703 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| Invention of 3Mint for feature grouping and scoring in multi-omics. | Front Genet | 2023 | 37007972 | PubTator, text mining | PubMed |
| Glycosaminoglycans: What Remains To Be Deciphered? | JACS Au | 2023 | 37006755 | PubTator, text mining | PubMed |
| 2-Aminobenzothiazoles in anticancer drug design and discovery. | Bioorg Chem | 2023 | 36989736 | PubTator, text mining | PubMed |
| BCL-XL Overexpression Protects Pancreatic β-Cells against Cytokine- and Palmitate-Induced Apoptosis. | Int J Mol Sci | 2023 | 36982731 | PubTator, text mining | PubMed |
| Naringenin and Hesperidin as Promising Alternatives for Prevention and Co-Adjuvant Therapy for Breast Cancer. | Antioxidants (Basel) | 2023 | 36978836 | PubTator, text mining | PubMed |
| An evaluation of programs to support new investigators at the National Institute of Allergy and Infectious Diseases: Striking a balance with funding for established investigators. | Eval Program Plann | 2023 | 36963190 | PubTator, text mining | PubMed |
Novel gold(I) complexes induce apoptosis in leukemia cells via the ROS-induced mitochondrial pathway with an upregulation of Harakiri and overcome multi drug resistances in leukemia and lymphoma cells and sensitize drug resistant tumor cells to apoptosis in vitro. | Biomed Pharmacother | 2023 | 36958194 | PubTator, text mining | PubMed |
| Identification of circRNA-miRNA-mRNA regulatory network and its role in cardiac hypertrophy. | PLoS One | 2023 | 36952519 | PubTator, text mining | PubMed |
| Virtual and Reality: An Analysis of the UCLA Virtual Crossmatch Exchanges. | Transplantation | 2023 | 36944607 | PubTator, text mining | PubMed |
| Hypoxia-induced autophagy in triple negative breast cancer: association with prognostic variables, patients' survival and response to neoadjuvant chemotherapy. | Virchows Arch | 2023 | 36939902 | PubTator, text mining | PubMed |
| Nicotinamide riboside supplementation is not associated with altered methylation homeostasis in Parkinson's disease. | iScience | 2023 | 36936793 | PubTator, text mining | PubMed |
| The JAK-STAT pathway promotes persistent viral infection by activating apoptosis in insect vectors. | PLoS Pathog | 2023 | 36928081 | PubTator, text mining | PubMed |
| Augmenting Venetoclax Activity Through Signal Transduction in AML. | J Cell Signal | 2023 | 36911757 | PubTator, text mining | PubMed |
| PROTACs: Walking through hematological malignancies. | Front Pharmacol | 2023 | 36909156 | PubTator, text mining | PubMed |
| Temperature Field, Flow Field, and Temporal Fluctuations Thereof in Ammonothermal Growth of Bulk GaN-Transition from Dissolution Stage to Growth Stage Conditions. | Materials (Basel) | 2023 | 36903128 | PubTator, text mining | PubMed |
| Venetoclax-Resistant T-ALL Cells Display Distinct Cancer Stem Cell Signatures and Enrichment of Cytokine Signaling. | Int J Mol Sci | 2023 | 36902436 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8739/papers?page=8